Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer

Clinical trial NCT00160069 · COMPLETED

Trial details

NCT number: NCT00160069
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non Small Cell Lung

Start date: 2005-08-01
Primary completion: 2008-04-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.